DANAHER CORP /DE/ (DHR) Stock Price, Financials & Summary

Price chart

Oct 1Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30

Key dataOct 30, 2026

Open$237.91

From 52W high−4.05%

Volume3.74M

Market cap$163.40B

P/E (TTM)37.9x

P/S (TTM)6.4x

Div yield0.65%

Key dataOct 30, 2026

Open

$237.91

From 52W high

−4.05%

Volume

3.74M

Market cap

$163.40B

ValuationView details →

P/E (Fwd)

25.5x

EV/EBITDA

26.0x

P/E (TTM)

37.9x

RSI (14)

57.8

MomentumView details →

1D Return

−2.00%

YTD Return

+1.33%

SummaryUpdated Sep 1, 2026

Danaher Corporation (NYSE:DHR) is a diversified life sciences and diagnostics company founded in 1969 and headquartered in Washington, D.C. Originally established as Diversified Mortgage Investors, Inc., the company underwent a significant transformation and changed its name to Danaher Corporation in 1984. Over the decades, Danaher has evolved from a diversified industrial conglomerate into a focused life sciences powerhouse through strategic acquisitions and divestitures. The company went public in 1978 and has since built a portfolio of leading brands serving the biotechnology, life sciences research, and clinical diagnostics markets worldwide.

Ask drillr about DANAHER CORP /DE/ →

ValuationView details →

P/E (Fwd)

25.5x

P/E (TTM)

37.9x

EV/EBITDA

26.0x

EV/Sales

7.2x

P/S (TTM)

6.4x

P/B (TTM)

3.0x

ProfitabilityView details →

Gross Margin

58.59%

Net Margin

16.91%

EBITDA Margin

27.67%

ROE (TTM)

8.08%

ROA (TTM)

4.64%

Asset Turnover

0.28x

GrowthView details →

Revenue YoY

+5.52%

EPS YoY

+25.41%

FCF YoY

+14.15%

Revenue CAGR 3Y

−2.67%

EPS CAGR 3Y

−19.72%

EBITDA YoY

+3.23%

MomentumView details →

1D Return

−2.00%

YTD Return

+1.33%

1Y Return

+7.70%

RSI (14)

57.8

vs 50D SMA

+6.00%

vs 200D SMA

+15.34%

Capital & dividendView details →

Debt/Equity

0.49x

Current Ratio

1.63x

Quick Ratio

1.29x

Div Yield

0.65%

Div Rate

$1.52

Div Growth 1Y

+18.52%

EarningsView details →

EPS (Actual)

$2.11

EPS Surprise

9.78%

Beats (12Q)

11/12

Next Q EPS Est

$2.48

Avg Surprise (4Q)

5.99%

Rev Surprise

0.09%

Financials snapshotView financials →

Revenue (TTM)

25.61B

Net Income (TTM)

4.33B

Op. CF (TTM)

6.86B

Next earningsJan 27, 2027 →

Latest newsMore news →

Genedata AG announced that it had added NVIDIA CORP’s RFD4-Proteina binder-design model to its AI-enabled production discovery workflows.11d ago

DANAHER CORP /DE/ raised its adjusted earnings outlook for 2026.12d ago

Similar companies

Thermo Fisher Scientific Inc.TMO WuXi XDC Cayman Inc02268.HK Access Bio, Inc.950130.KQ 药明康德603259.SH Natera, Inc.NTRA WuXi AppTec Co., Ltd.02359.HK Find similar companies →

Latest newsMore news →

Genedata AG announced that it had added NVIDIA CORP’s RFD4-Proteina binder-design model to its AI-enabled production discovery workflows.11d ago DANAHER CORP /DE/ raised its adjusted earnings outlook for 2026.12d ago DANAHER CORP /DE/ reported quarterly earnings of $2.11 per share, above the Zacks Investment Research, Inc. consensus estimate of $1.92 and compared with $1.89 per share a year earlier.12d ago